Synovus Financial’s BioNTech BNTX Stock Holding History

Synovus Financial’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,980	Closed	-$322K	–	841
2023 Q2	$322K	Sell	2,980 -10	-0.3%	-$1.13K	﹤0.01%	714
2023 Q1	$372K	Hold	2,990	–	–	﹤0.01%	679
2022 Q4	$449K	Hold	2,990	–	–	0.01%	638
2022 Q3	$402K	Hold	2,990	–	–	﹤0.01%	629
2022 Q2	$446K	Hold	2,990	–	–	0.01%	613
2022 Q1	$511K	Hold	2,990	–	–	0.01%	616
2021 Q4	$771K	Buy	2,990 +400	+15%	+$110K	0.01%	519
2021 Q3	$707K	Hold	2,590	–	–	0.01%	526
2021 Q2	$579K	Hold	2,590	–	–	0.01%	580
2021 Q1	$282K	Buy	+2,590	New	+$275K	﹤0.01%	659

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Synovus Financial's BNTX Position: Q3 2023 in Review

Synovus Financial sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 2,980 shares — an estimated $322K sold.

Synovus Financial first reported a position in BNTX in Q1 2021 and held it in 10 quarters. The position peaked at $771K in Q4 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Synovus Financial reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Synovus Financial sold 2,980 BioNTech shares in Q3 2023, an estimated $322K.
Synovus Financial first reported a position in BioNTech in Q1 2021 and held it in 10 quarters.
Synovus Financial's BioNTech position peaked at $771K in Q4 2021.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Synovus Financial's 13F filing for Q3 2023, filed 13 Nov 2023.